MoneyWorks4Me

Ishita Drugs & Inds. - Quaterly Results

12 Aug 2025 Evaluate
The topline stands at Rs. 54.00 millions for the June 2025 quarter. The mentioned figure indicates a rise of about 78.34% as against Rs. 30.28 millions during the year-ago period.Net Profit witnessed a 106.12% growth almost the double from Rs. 1.47 millions to Rs. 3.03  millions  of same quarter last year.OP of the company witnessed a marginal growth to 4.39 millions from 2.32 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 54.00 30.28 78.34 54.00 30.28 78.34 149.97 151.88 -1.26
Other Income 0.91 0.58 56.90 0.91 0.58 56.90 3.36 2.80 20.00
PBIDT 4.39 2.32 89.22 4.39 2.32 89.22 13.38 11.88 12.63
Interest 0.23 0.08 187.50 0.23 0.08 187.50 0.72 0.90 -20.00
PBDT 4.16 2.24 85.71 4.16 2.24 85.71 12.66 10.98 15.30
Depreciation 0.28 0.28 0.00 0.28 0.28 0.00 1.10 1.12 -1.79
PBT 3.88 1.96 97.96 3.88 1.96 97.96 11.56 9.86 17.24
TAX 0.85 0.49 73.47 0.85 0.49 73.47 2.87 2.39 20.08
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.08 -0.01 700.00
PAT 3.03 1.47 106.12 3.03 1.47 106.12 8.69 7.47 16.33
Equity 29.90 29.90 0.00 29.90 29.90 0.00 29.90 29.90 0.00
PBIDTM(%) 8.13 7.66 6.11 8.13 7.66 6.11 8.92 7.82 14.06
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..